Forest Labs to Buy Aptalis for $2.9 Billion
- January 08, 2014
Forest Laboratories Inc. agreed to buy specialty pharmaceutical company Aptalis Holdings Inc. for $2.9 billion in cash. Private-equity firm TPG purchased Aptalis, at the time called Axcan Pharma Inc., in 2008 ... Read More